Medical University Innsbruck
Innsbruck, 6020, Austria
NCT Number: NCT07564349
This prospective, randomized, multi-arm study evaluates the usability and performance of commercially available CE-certified 7-day ECG patches in an outpatient setting. Participants aged ≥65 years requiring ECG monitoring as part of routine care will be randomized to one of six ECG patch devices. The study aims to assess the proportion of analyzable ECG recordings and overall recording quality over a 7-day period.
This study is active but is not currently recruiting participants.
65 year and older
All sexes
Interventional
Not applicable
Innsbruck, 6020, Austria
Atrial fibrillation is a common arrhythmia often underdiagnosed due to its intermittent nature. Long-term ECG monitoring using wearable patch devices has emerged as an important diagnostic tool. However, comparative data between available devices are lacking.
This randomized study compares six commercially available ECG patches regarding usability, adherence, and recording quality in an elderly outpatient population. Participants will independently apply the assigned device and undergo 7-day ECG monitoring. Device performance and patient feedback will be systematically assessed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CE-certified multi-parameter ECG patch including additional physiological monitoring
CE-certified ECG patch with smartphone-based data transmission.
CE-certified ECG patch designed for long-term continuous rhythm monitoring.
CE-certified multi-lead ECG patch for continuous cardiac monitoring
CE-certified 3 lead ECG patch designed for long-term continuous rhythm monitoring.
CE-certified single-lead ECG patch for long-term continuous rhythm monitoring
Time frame: 7 days
The proportion of participants who achieve at least 24 hours of analyzable ECG recording during the 7-day monitoring period. Analyzable ECG recording is defined as ECG data of sufficient technical quality to allow rhythm assessment, as determined by the certified analysis algorithm provided by the device manufacturer. Periods with insufficient signal quality (e.g., due to noise, signal loss, or artifacts) are excluded.
Time frame: 7 days
Cumulative duration, in hours, of analysable ECG obtained per participant during the intended 7-day monitoring period, where analysable ECG is defined as ECG of sufficient quality, according to the manufacturer's signal-quality criteria, to permit rhythm analysis. Participants without any recording were assigned a value of 0 hours.
Medical University Innsbruck
Other
Comparison of Commercially Available 7-Day ECG Patches: A Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07402798
Arrhythmias, Cardiac, Atrial Fibrillation
Barcelona, Barcelona, Spain, Spain
View Trial DetailsNCT06892938
Arrhythmias Cardiac, Arrhythmias, Cardiac
La Jolla, California, United States
View Trial DetailsNCT07711327
Arrhythmias, Cardiac, Atrial Fibrillation
Duarte, California, United States
View Trial DetailsNCT07444372
Apnea, Arrhythmia
Beijing, Beijing Municipality, China
View Trial Details